Secukinumab Provides Early and Long Lasting Pain Relief in Biologic-naïve Patients with Psoriatic Arthritis: 2-Year Results from the Future-2 Study. 19th Asia Pacific League of Associations for Rheumatology Congress (APLAR 2017), Dubai, U.A.E., Oct 2017.